Perhaps the BOD has cried wolf too many times with their Friday trading halts. So predictable, that this one was even predicted by some on this forum! But this one, just like the last few, couldn't even attract day traders trying to pump and dump the release! Couldn't even hold onto yesterdays close! Another fluffy announcement, with yet another claim in its title which is not supported in anyway in the announcement text.
Looks like the market thinks they should be concentrating on achieving at least one thing, rather than just promising lots of things. Lots of red flags here until they follow through on at least one project.
Some heavy ramping by the same names on these forums. I wonder if its just the same person with different handles? Anyone who questions what is happening gets shouted down.
How can an Oil sales company have a market cap of over 200 million? Real Bio tech companies have this MC, or even less, when conducting Phase 2 trials. Phase 2 trials, by the way, are when humans are involved. Can anyone find any pre-clinical phase company with a similar MC?
But at least we know the rats are doing ok.
Also a very good idea to wait until tomorrow to top up Chaya, as the "numbnuts" will continue to sell. Wait a bit longer and you will save even more money.
Removing this one from the watch list.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-675A outperforms existing treatment for arthritis
Ann: IHL-675A outperforms existing treatment for arthritis, page-80
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online